Quarterly report pursuant to Section 13 or 15(d)

STOCK-BASED COMPENSATION (Tables)

v3.23.3
STOCK-BASED COMPENSATION (Tables)
9 Months Ended
Sep. 30, 2023
STOCK-BASED COMPENSATION  
Summary of the expense for stock-based compensation related to stock option grants

Three Months Ended

Nine Months Ended

September 30, 

September 30, 

    

2023

    

2022

    

2023

    

2022

Employee and director stock option grants:

 

  

 

  

 

  

 

  

Research and development

$

89,172

$

37,211

$

227,896

$

123,638

General and administrative

 

408,706

 

330,548

 

1,097,945

 

967,879

Total stock-based compensation

$

497,878

$

367,759

$

1,325,841

$

1,091,517